Saudi Press

Saudi Arabia and the world
Tuesday, Apr 07, 2026

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

"I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover. It will certainly be Oxford AstraZeneca, that I will be having," Boris Johnson said .

British Prime Minister Boris Johnson said on Wednesday he will take the vaccine developed by AstraZeneca after a number of European countries halted their rollout of the jab over safety fears.

Johnson dismissed questions in parliament about why several countries had suspended use of the product developed by the British-Swedish pharmaceutical company with scientists at Oxford University.

But he told lawmakers: "I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover.

"It will certainly be Oxford AstraZeneca, that I will be having."

Johnson, 56, is among the next category of people being called for vaccination. The government hopes to have offered it to all adults by July.

Health Secretary Matt Hancock said that timeline remains on track, despite the National Health Service in England warning in a letter to administrators that vaccine supplies will be "significantly constrained" from March 29 for up to a month.

"Vaccine supply is always lumpy and we regularly send out technical letters to the NHS to explain the ups and downs of the supply over the future weeks," Hancock told a news conference, insisting the letter was "standard" practice.

Britain has now given more than 25 million people a first dose of a Covid vaccine -- including 11 million doses of the AstraZeneca jab -- after starting a mass inoculation programme in December last year.

It is also using a jab developed by Pfizer/BioNTech in its rollout programme but recipients do not normally get a choice of vaccines.

Johnson wrote in the Times newspaper that the AstraZeneca vaccine "is safe and works extremely well". Hancock and England's deputy chief medical officer Jonathan Van-Tam echoed that assurance at the press conference.

- Royal intervention -


European countries including France, Spain and Germany are among those who have halted using the jab pending a review by the European Medicines Agency (EMA) amid feared links to blood clots and brain haemorrhages.

Queen Elizabeth II's oldest son and heir, Prince Charles, on Wednesday criticised opposition to coronavirus vaccines.

"Who would have thought, for instance, that in the 21st century that there would be a significant lobby opposing vaccination, given its track record in eradicating so many terrible diseases," he said in an article in the Future Healthcare Journal.

Charles, who has been vocal in advocating the rollout of the vaccine among more reluctant minority communities in Britain, added that the jab had the "potential to protect and liberate some of the most vulnerable in our society from coronavirus".

The 72-year-old Prince of Wales tested positive for coronavirus last year and suffered mild symptoms. He had his first dose of a vaccine in February.

His wife, Camilla, 73, confirmed on Tuesday she had been given the AstraZeneca shot.

"You take what you are given," she said as the couple visited a vaccination centre at a north London mosque, adding that she had suffered no ill-effects.

- 'No evidence' -


Professor Jeremy Brown, from the government's Joint Committee on Vaccination and Immunisation (JCVI), said suspension of the AstraZeneca jab was "not logical".

"There is the concern that what's happening in Europe might make people in the UK less confident in the AstraZeneca vaccine," he told broadcaster ITV.

The EMA, the World Health Organization and Britain's Medicines and Healthcare products Regulatory Agency have all backed the AstraZeneca jab.

France and Italy have said they will "promptly restart" giving the jab if the EMA review allows it.

As Britain has surged ahead with its vaccination programme, European countries have been accused of playing politics to distract from their sluggish inoculation rollouts.

European leaders were angered in January after AstraZeneca announced it was unable to deliver the agreed numbers of jabs to the bloc.

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Taiwan to Source Oil Shipments from Saudi Arabia’s Red Sea Ports
Saudi Arabia Evacuates Riyadh Financial District as Precaution Amid Regional Tensions
Saudi Arabia Balances Ambitious Economic Vision Amid Regional Tensions and Financial Pressures
Budget Saudi Arabia Reports Strong Full-Year 2025 Financial Performance
Saudi Arabia Expands Investment in Capcom With Stake Reaching Six Percent
Saudi Arabia Assesses Significant Economic Impact From Regional Conflict Involving Iran
US Beef Secures Expanded Market Access in Saudi Arabia
Jordan and Saudi Arabia Declare Absolute Solidarity in Response to Iranian Threats
Saudi Arabia Raises Oil Prices to Record Premium Amid Strong Market Demand
California’s Salton Sea Emerges as Strategic Lithium Hub for Clean Energy Future
Iranian Drone Strike on US Embassy in Saudi Arabia Reportedly Targeted Intelligence Facility
Saudi Deputy Foreign Minister Meets French Embassy Official to Strengthen Bilateral Engagement
Saudi Arabia Calls on United States to Seize Strategic Opportunity to Reshape Middle East
Dating Apps Surge in Saudi Arabia as Social Norms Rapidly Evolve Among Youth
Saudi Arabia Detains Over Fourteen Thousand Illegal Residents in Week-Long Enforcement Drive
Saudi Foreign Minister Engages in Diplomatic Talks with Pakistan, Kuwait and Latvia on Regional Developments
Saudi Arabia Intercepts Cruise Missile as Regional Tensions Intensify
Saudi Stock Market Edges Higher as Tadawul Index Records Modest Gain
Underlying Rivalry Between Saudi Arabia and UAE Persists Despite Temporary Calm
Saudi Arabia’s Non-Oil Sector Contracts in March as Regional Tensions Weigh on Business Activity
Saudi Arabia Unveils Ambition to Establish Prestigious Global Prize Rivaling the Nobel
Saudi Crown Prince to Engage Wall Street in Push for Investment and Economic Expansion
Iran Accuses Saudi Arabia and UAE After Downing of Chinese-Made Drone
Saudi Arabia Condemns Attack on Hospital in Sudan, Calls for Protection of Civilians
Coordinated Drone Strike Targets CIA Facility Within US Embassy in Saudi Arabia
Italy’s Meloni Prioritises Energy Security and Strait of Hormuz Stability During Gulf Tour
Uncertainty Emerges Over Timeline and Direction of Saudi Arabia’s Ambitious Ski Resort Project
UAE and Saudi Arabia Escalate Strategy with Drone Operations Targeting Iran
Trump Delivers Characteristic Remarks on Saudi Crown Prince Amid Intensifying Iran Conflict
Drone Strike on US Embassy in Riyadh Caused Greater Damage Than First Reported
Saudi Arabia Introduces Flexible Solutions for Expired Visas Amid Regional Disruptions
Saudi Arabia’s Online Car Market Accelerates with AI Pricing and Fully Digital Buying Experience
Saudi Arabia Reassesses Defence Strategy as Iranian Drone Threat Drives Shift in Military Partnerships
Drone Strikes Target Saudi Arabia, Kuwait and Bahrain as Regional Conflict Intensifies
Japan and Saudi Arabia Align Efforts to Ease Rising Tensions with Iran
Saudi Crown Prince and Italy’s Meloni Strengthen Strategic Ties in High-Level Talks
SpaceX Explores Potential Five Billion Dollar Investment from Saudi Sovereign Wealth Fund Ahead of IPO
Saudi Arabia Lifts Key Import Barriers to Expand Access for U.S. Beef Exports
Saudi Arabia Enforces Strict Travel Penalties for Visits to Restricted Countries
Italy’s Meloni Embarks on Strategic Gulf Tour to Address Energy Security and Regional Stability
Saudi Film Festival Rescheduled to Summer as Regional Tensions Continue
Saudi Arabia Reports Forty Two Point Six Billion Dollars in Foreign Tourist Spending in 2025
Saudi Crown Prince and Russian President Hold Strategic Call on Escalating Regional Crisis
Saudi Arabia Advances Rail Network as Strategic Alternative to Strait of Hormuz Shipping Route
Ruanyun Edai Launches Saudi Arabia Hub With Forecast of Ten Percent Revenue Growth
Greek Defence Minister Visits Troops in Saudi Arabia Following Successful Missile Interception
Saudi Arabia Expands Global Strategy With Focus on African Critical Minerals
SpaceX Explores Potential Five Billion Dollar Investment From Saudi Fund Ahead of Possible IPO
US Central Command Dismisses Iranian Claim of Mass Casualties Among American Personnel in Saudi Arabia
Co-Diagnostics to Establish Molecular Diagnostics Facility in Saudi Arabia Through Joint Venture
×